info@marketresearchfuture.com   📞  +1 (855) 661-4441(US)   📞  +44 1720 412 167(UK)
Certified Global Research Member
Isomar fd.webp Wcrc 57.webp
Key Questions Answered
  • Global Market Outlook
  • In-depth analysis of global and regional trends
  • Analyze and identify the major players in the market, their market share, key developments, etc.
  • To understand the capability of the major players based on products offered, financials, and strategies.
  • Identify disrupting products, companies, and trends.
  • To identify opportunities in the market.
  • Analyze the key challenges in the market.
  • Analyze the regional penetration of players, products, and services in the market.
  • Comparison of major players’ financial performance.
  • Evaluate strategies adopted by major players.
  • Recommendations
Why Choose Market Research Future?
  • Vigorous research methodologies for specific market.
  • Knowledge partners across the globe
  • Large network of partner consultants.
  • Ever-increasing/ Escalating data base with quarterly monitoring of various markets
  • Trusted by fortune 500 companies/startups/ universities/organizations
  • Large database of 5000+ markets reports.
  • Effective and prompt pre- and post-sales support.

Anxiety Disorder Treatment Companies

Anxiety disorders encompass a range of mental health conditions characterized by excessive worry, fear, or nervousness. Treatment approaches often include psychotherapy, medications, or a combination of both. Pharmaceutical companies play a significant role in the development and production of medications used in the treatment of anxiety disorders.

Anxiety Disorder Treatment Key CompaniesLatest Anxiety Disorder Treatment Companies Update

February 2023: Biogen Inc. and Sage Therapeutics, Inc. have jointly declared that their New Drug Application (NDA) for zuranolone, a treatment for major depressive disorder (MDD) and postpartum depression (PPD), has been approved by the U.S. Food and Drug Administration (FDA). An investigational substance, Zuranolone, is undergoing clinical evaluation as a once-daily, rapid-acting, 14-day oral treatment for adults diagnosed with MDD and PPD. Priority review has been allotted to the application, and August 5, 2023 has been designated as the Prescription Drug User Fee Act (PDUFA) action date by the FDA. The NDA for zuranolone comprises information derived from the LANDSCAPE and NEST clinical development programs, in addition to a Phase 2 study conducted by Shionogi in Japan involving adults diagnosed with MDD.


November 2022: The Institute of Mental Health and the Singaporean technology startup Neeuro have jointly introduced a home-based attention training program.   Cogo is a digital therapeutic program designed to address inattentiveness in children ages 6 to 12 by pairing a 24-session guided game with the Neeuro SenzeBand 2 EEG headgear. It was created utilizing the Brain-Computer Interface technology of Neeuro. The objective of the mobile game, as stated in a press release, is to guide a character through a labyrinth. In contrast to most games, in which the user interacts with the characters via a touchscreen or gamepad, Cogo exclusively utilizes brainwaves to control the characters. Its associated headgear monitors the brainwaves of users via seven EEG sensors with four distinct data channels. Subsequently, these are captured and interpreted by AI algorithms, which utilize the real-time Bluetooth transmissions to generate challenges within the game.


List of Anxiety Disorder Treatment Key companies in the market

  • Bristol-Myers Squibb Company (US)

  • Lundbeck A/S (Denmark)

  • Johnson and Johnson (US)

  • GlaxoSmithKline PLC (UK)

  • Pfizer

  • Merck & Co.

  • Sanofi-Aventis (France)

  • AstraZeneca PLC (UK)

  • Forest Laboratories

  • Eli Lily and Company (US)

Leading companies partner with us for data-driven Insights
client_1 client_2 client_3 client_4 client_5 client_6 client_7 client_8 client_9 client_10
Kindly complete the form below to receive a free sample of this Report
Please fill in Business Email for Quick Response

We do not share your information with anyone. However, we may send you emails based on your report interest from time to time. You may contact us at any time to opt-out.

Purchase Option
Single User $ 4,950
Multiuser License $ 5,950
Enterprise User $ 7,250
Compare Licenses
Tailored for You
  • Dedicated Research on any specifics segment or region.
  • Focused Research on specific players in the market.
  • Custom Report based only on your requirements.
  • Flexibility to add or subtract any chapter in the study.
  • Historic data from 2014 and forecasts outlook till 2040.
  • Flexibility of providing data/insights in formats (PDF, PPT, Excel).
  • Provide cross segmentation in applicable scenario/markets.